Group One Trading, L.P. Theravance Biopharma, Inc. Transaction History

Group One Trading, L.P.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$10.16 - $11.92 $5,516 - $6,472	-543 Reduced 15.03%	3,069 $31,000
Q1 2023 May 12, 2023	BUY	$9.87 - $11.44 $35,650 - $41,321	3,612 New	3,612 $39,000
Q3 2022 Nov 09, 2022	BUY	$8.39 - $10.22 $16,217 - $19,755	1,933 Added 115.4%	3,608 $37,000
Q2 2022 Aug 11, 2022	SELL	$8.41 - $10.34 $58,870 - $72,380	-7,000 Reduced 80.69%	1,675 $15,000
Q1 2022 May 12, 2022	SELL	$8.33 - $12.96 $302,628 - $470,836	-36,330 Reduced 80.72%	8,675 $83,000
Q4 2021 Feb 11, 2022	SELL	$7.42 - $11.05 $148,793 - $221,585	-20,053 Reduced 30.82%	45,005 $497,000
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $440,442 - $937,485	65,058 New	65,058 $481,000
Q1 2020 May 13, 2020	SELL	$17.84 - $31.21 $11,364 - $19,880	-637 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$16.12 - $25.89 $259,532 - $416,829	-16,100 Reduced 96.19%	637 $16,000
Q3 2019 Nov 12, 2019	SELL	$16.51 - $23.78 $707,139 - $1.02 Million	-42,831 Reduced 71.9%	16,737 $326,000
Q2 2019 Aug 09, 2019	BUY	$15.6 - $25.15 $748,659 - $1.21 Million	47,991 Added 414.54%	59,568 $973,000
Q1 2019 May 13, 2019	BUY	$22.57 - $28.15 $261,292 - $325,892	11,577 New	11,577 $262,000
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $24,266 - $28,072	-1,100 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$23.37 - $29.71 $25,707 - $32,681	1,100 New	1,100 $27,000
Q4 2017 Feb 09, 2018	SELL	$25.82 - $35.66 $90,370 - $124,809	-3,500 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$23.88 - $34.96 $83,580 - $122,360	3,500	3,500 $120,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.